Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
Authors
Keywords
-
Journal
LANCET INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-01-19
DOI
10.1016/s1473-3099(22)00801-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
- (2022) Heba N. Altarawneh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coronavirus Disease 2019 (COVID-19) Vaccine Boosting in Previously Infected or Vaccinated Individuals
- (2022) Nabin K. Shrestha et al. CLINICAL INFECTIOUS DISEASES
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study
- (2022) Sivan Gazit et al. CLINICAL INFECTIOUS DISEASES
- COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants – surveillance results from southern Sweden, December 2021 to March 2022
- (2022) Jonas Björk et al. Eurosurveillance
- Protection by vaccines and previous infection against the Omicron variant of SARS-CoV-2
- (2022) Martin Šmíd et al. JOURNAL OF INFECTIOUS DISEASES
- Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
- (2022) Daniel R Feikin et al. LANCET
- Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
- (2022) Tommy Nyberg et al. LANCET
- Vaccination plus previous infection: protection during the omicron wave in Brazil
- (2022) Thiago Cerqueira-Silva et al. LANCET INFECTIOUS DISEASES
- Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022
- (2022) Ian D. Plumb et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant
- (2022) Melissa M Higdon et al. LANCET INFECTIOUS DISEASES
- Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections
- (2022) Heba N. Altarawneh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
- (2022) Stijn P. Andeweg et al. Nature Communications
- Post-vaccination T cell immunity to omicron
- (2022) Henning Jacobsen et al. Frontiers in Immunology
- Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses
- (2022) Clarisa M. Buckner et al. CELL
- Long-term neurologic outcomes of COVID-19
- (2022) Evan Xu et al. NATURE MEDICINE
- Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies
- (2022) Isabel Bergeri et al. PLOS MEDICINE
- Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review
- (2022) Kin Israel Notarte et al. EClinicalMedicine
- COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates
- (2021) Malik Sallam Vaccines
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
- (2021) Matthew J. Page et al. PLOS MEDICINE
- Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection
- (2021) Barbara H. Bardenheier et al. Journal of the American Medical Directors Association
- Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021
- (2021) Lyudmyla Kompaniyets et al. Preventing Chronic Disease
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Depletion of Susceptibles Bias in Analyses of Intra-season Waning of Influenza Vaccine Effectiveness
- (2019) G Thomas Ray et al. CLINICAL INFECTIOUS DISEASES
- Meta-Analysis of Effect Sizes Reported at Multiple Time Points Using General Linear Mixed Model
- (2016) Alfred Musekiwa et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started